Paid Clinical Trials in Glendale, AZ
As of August 2026, 59 paid clinical trials are recruiting in Glendale, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Glendale offers studies at sites including Ironwood Cancer & Research Centers for conditions such as Amblyopia, Heart Failure, Colorectal Neoplasms, Gout. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Glendale
Trials by drug in Glendale
Filter results
Newly added in Glendale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
57 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Non-Invasive Preeclampsia Screening and Biobank
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
Top Research Study Locations in Glendale
Researchers run research studies in Glendale, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Ironwood Cancer & Research Centers | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Palo Verde Hematology Oncology | Anaplastic Lymphoma Kinase-positive, Colorectal Neoplasms, Metastatic Castration-Resistant Prostate Cancer | 5 |
| Sun City Clinical Research | Diabetic Peripheral Neuropathic Pain, Heart Failure, Moderately to Severely Active Crohns Disease | 4 |
| Midwestern University Eye Institute | Amblyopia | 3 |
| AARA Clinical Research | Arthritis, Psoriatic, Lupus Nephritis | 2 |
| AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Glendale | Dermatomyositis, Overweight or Obesity, Polymyositis | 2 |
| Arizona Arthritis & Rheumatology Associates (AARA) - Glendale | Gout, Tophaceous Gout | 2 |
| Valley Perinatal | Preeclampsia (PE), Single Gene NIPT | 2 |
| Advanced Research Associates - Glendale | Acne Scars, Mid Face Volume Deficit | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| AARA Arizona Arthritis & Rheumatology Associates, P.C. - Glendale | Radiographic Axial Spondyloarthritis | 1 |
| AKDHC Medical | End Stage Kidney Disease | 1 |
| Advanced Research Associates | Moderate to Severe Glabellar Lines | 1 |
| Arizona Advanced Eye Research | Open Angle Glaucoma (OAG) | 1 |
| Arizona Advanced Eye Research Institute | Primary Open Angle Glaucoma | 1 |
| Arizona Arthritis & Rheumatology Associates | Active Rheumatoid Arthritis | 1 |
| Arizona Arthritis & Rheumatology Associates, PLLC | Primary Sjogren's Disease | 1 |
| Arizona Arthritis & Rheumatology Research, PLLC | Myositis | 1 |
| Arizona Arthritis & Rheumatology Associates - Glendale | Acute Gout Flare, Arthritis, Gout | 1 |
| Arizona Arthritis and Rheumatology Associates - Glendale - 5681 W Beverly Ln | Sjögren's Syndrome | 1 |
| Arizona Heart & Vascular Clinic | Acute Coronary Syndrome | 1 |
| Arizona Kidney Disease & Hypertension Centers (AKDHC) | IgA Nephropathy | 1 |
| Atlas Pain Spcltsts | Lumbar Spinal Stenosis | 1 |
| Central Recruiting Site | Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain, Chemotherapy Induced Pain Neuropathy | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
Active & Upcoming Studies in Glendale (2026)
Recruiting trials in Glendale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (10 active studies)
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
Neurology & pain (5 active studies)
- The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity · Mayo Clinic
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Cardiovascular (5 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Diabetes & metabolic (4 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes · Phase 3 · Kailera
Eye & vision (2 active studies)
- Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma · Avisi Technologies Inc.
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
Mental health & behavior (1 active study)
- A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) · Phase 3 · Bristol-Myers Squibb
Common conditions studied in Glendale
- Amblyopia (3 active studies)
- Heart Failure (3 active studies)
- Colorectal Neoplasms (2 active studies)
- Gout (2 active studies)
- Obesity (2 active studies)
- Systemic Lupus Erythematosus (2 active studies)
Leading research sponsors in Glendale
- Pfizer
- AbbVie
- Jaeb Center for Health Research
- Merck Sharp & Dohme LLC
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Glendale?
There are approximately 59 recruiting clinical trials in Glendale, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Glendale pay participants?
Most recruiting trials in Glendale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Glendale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Glendale?
The most common conditions under active study in Glendale include Amblyopia (3), Heart Failure (3), Colorectal Neoplasms (2), Gout (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Glendale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Glendale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Glendale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Glendale?
Recruiting research sites in Glendale include Ironwood Cancer & Research Centers, Palo Verde Hematology Oncology, Sun City Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Glendale right now?
The largest active categories in Glendale are Cancer & tumors (10), Neurology & pain (5), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.